Genkin Dmitry 4
4 · Xenetic Biosciences, Inc. · Filed Jul 23, 2019
Insider Transaction Report
Form 4
Genkin Dmitry
Director
Transactions
- Award
Common Stock
2019-07-19+93,390→ 93,603 total
Footnotes (1)
- [F1]Shares acquired in connection the closing of the transaction contemplated by that certain Share Purchase agreement, dated March 1, 2019, with Hesperix SA, a Swiss corporation ("Hesperix"), the owners of Hesperix (each, a "Seller" and collectively, the "Sellers"), and Alexey Andreevich Vinogradov, as the representative of each Seller. The Reporting Person was a Seller in the transaction. On the closing date, the closing price of the Issuer's common stock was $4.85.